Cargando…
Long-lasting oral analgesic effects of N-protected aminophosphinic dual ENKephalinase inhibitors (DENKIs) in peripherally controlled pain
The peripheral endogenous opioid system is critically involved in neuropathic and inflammatory pain generation as suggested by the modulation of opioid receptors expression and enkephalins (ENKs) release observed in these painful conditions. Accordingly, an innovative approach in the treatment of th...
Autores principales: | Bonnard, Elisabeth, Poras, Hervé, Nadal, Xavier, Maldonado, Rafael, Fournié-Zaluski, Marie-Claude, Roques, Bernard P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324690/ https://www.ncbi.nlm.nih.gov/pubmed/25692029 http://dx.doi.org/10.1002/prp2.116 |
Ejemplares similares
-
Actualización de la computadora personal Denki Corona /
por: Amaro Aldana, José Antonio
Publicado: (1994) -
Actualización de una computadora Denki Corona 8088 a 80486 /
por: Ramírez Gómez, Demetrio
Publicado: (1995) -
Angiotensin-converting enzyme and enkephalinase in human breast cyst fluid.
por: Frame, K. L., et al.
Publicado: (1996) -
First‐in‐human trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of STR‐324, a dual enkephalinase inhibitor for pain management
por: Moss, Laurence M., et al.
Publicado: (2021) -
Design of the first highly potent and selective aminopeptidase N (EC 3.4.11.2) inhibitor
por: Huixiong Chen, et al.
Publicado: (1999)